# Heparin

## HEPAC inj 25KIU/5mL

##### 

| TAH Drug Code      | [IHEPA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IHEPA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Unstable angina; Venous thromboembolism; Peripheral arterial embolism, Prevention of re-occlusion of the coronary arteries following thrombolytic therapy , Venous thromboembolism ,Prophylaxis of post-op venous thromboembolism, Prevention of mural thrombosis                                                                                                                                                                                                                                                                                                                             |
| Dosing             | IV: 10000 IU as first dose, followed by 5000-10000 IU every 4-6 hours. IV infusion: 20000-40000 IU/day, adding in 1000mL solvent. Deep SC: 10000 IU every 8 hours or 15000-20000 IU every 12 hours.                                                                                                                                                                                                                                                                                                                                                                                           |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | Patients predisposed to active bleeding including thrombocytopenia, peptic ulcer disease, cerebrovascular disorders, haemorrhagic blood disorders, bacterial endocarditis, severe hypertension, oesophageal varices. Recent surgery at sites where haemorrhage would be an especial risk. Severe renal and hepatic impairment. Cerebral or subarachnoid haemorrhage, abdominal or thoracic bleeding into closed space, severe traumatic bleed, hepatic, renal, splenic or arterial injury, severe haemostatic defect, arterial thrombosis with heparin-associated thrombocytopenia. IM admin. |
| Adverse Effects    | Slight fever, headache, chills, nausea, vomiting, constipation, epistaxis, bruising, slight haematuria, skin necrosis (SC inj), osteoporosis, alopecia. Hypersensitivity reactions include urticaria, conjunctivitis, rhinitis, asthma, angioedema and anaphylactic shock. Priapism. Potentially Fatal: Heparin-induced thrombocytopenia with or without thrombosis; bleeding Dermatologic: Erythema, Injection site ulcer, After deep subcutaneous injection Hematologic: Hematoma, Heparin-induced thrombocytopenia (up to 30% ) Neurologic: Pain (Mild) Other: Irritation symptom, Local   |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

## Hepac inj 1KIU/0.2mL

##### 

| TAH Drug Code      | [IHEPA1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IHEPA1)   |
|:-------------------|:---------------------------------------------------------------------------|
| Indications        | No Data                                                                    |
| Dosing             | No Data                                                                    |
| Hepatic Impairment | Dose adjustment not necessary                                              |
| Renal Impairment   | Dose adjustment not necessary                                              |
| Contraindications  | No Data                                                                    |
| Adverse Effects    | No Data                                                                    |
| Pregnancy          | Compatible                                                                 |
| Lactation          | Compatible                                                                 |

## Hepac Lock Flush 1000 Unit/10mL

##### 

| TAH Drug Code      | [IHLF](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IHLF)                                                                                                                     |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Solution is intended for maintenance of patency of intravenous injection devices only. (central line use)                                                                                |
| Dosing             | Adult dosing: Port-A flush only. Hepac Lock Flush Solution is intended for maintenance of patency of intravenous injection devices only and is not to be used for anticoagulant therapy. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                            |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                            |
| Contraindications  | Hypersensitivity to the drug, Bleeding disorders, Severe thrombocytopenia, Patients who can't undergo regular blood coagulation tests                                                    |
| Adverse Effects    | Hemorrhage, allergic reactions                                                                                                                                                           |
| Pregnancy          | Compatible                                                                                                                                                                               |
| Lactation          | Compatible                                                                                                                                                                               |

